A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/14 (2006.01) A61K 9/20 (2006.01) A61K 31/00 (2006.01) A61K 31/192 (2006.01) A61K 31/40 (2006.01) A61K 31/44 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2694378
Amorphous HMG CoA reductase inhibitors, especially amorphous atorvastatin, are described. Also described are pharmaceutical combinations comprising amorphous HMG CoA reductase inhibitors in combination with cholesterol absorption inhibitors or fibrates. A method of manufacturing the compositions using a hot melt extrusion process are also described.
L'invention concerne des inhibiteurs de HMG-CoA réductase sous forme amorphe, et notamment de l'atorvastatine amorphe. L'invention concerne également des combinaisons pharmaceutiques comprenant des inhibiteurs de HMG-CoA réductase sous forme amorphe en combinaison avec des inhibiteurs de l'absorption du cholestérol ou des fibrates. L'invention se rapporte en outre à un procédé de préparation de ces compositions au moyen d'une technique d'extrusion à chaud.
Amar Lulla
Geena Malhotra
Cipla Limited
Sim & Mcburney
LandOfFree
Pharmaceutical compositions and process for making them does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions and process for making them, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and process for making them will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1763979